Nanogels for delivery, imaging and therapy

Wiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology

Volumn 7, Issue 4, 2015, Pages 509-533

  Sivaram, Amal J ^a   Rajitha, P ^a   Maya, S ^a   Jayakumar, R ^a   Sabitha, M ^a  

^a AMRITA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ADHESIVES; BIOACTIVITY; CROSSLINKING; DISEASES; NANOSTRUCTURED MATERIALS; PROTEINS; TARGETED DRUG DELIVERY;

ANTI-INFLAMMATORIES; ANTI-INFLAMMATORY DRUGS; ARTIFICIAL CHAPERONE; CANCER DRUG DELIVERIES; CONTROLLED RELEASE; CROSS-LINKED POLYMERS; DRUG LOADING CAPACITY; TRANSDERMAL DRUG DELIVERY;

CONTROLLED DRUG DELIVERY;

ANTIINFLAMMATORY AGENT; ANTINEOPLASTIC AGENT; CHAPERONE; ENZYME; PEPTIDE; PROTEIN; MACROGOL DERIVATIVE; NANOGEL; POLYETHYLENEIMINE;

ARTICLE; DRUG DELIVERY SYSTEM; DRUG PENETRATION; GENE TARGETING; HUMAN; HYDROGEL; IMAGING; NONHUMAN; PH; PRIORITY JOURNAL; SKIN; ANIMAL; CHEMISTRY; DIAGNOSTIC IMAGING; GENE TRANSFER; PROCEDURES; SYNTHESIS;

ANIMALS; ANTI-INFLAMMATORY AGENTS; ANTINEOPLASTIC AGENTS; DIAGNOSTIC IMAGING; DRUG DELIVERY SYSTEMS; GENE TRANSFER TECHNIQUES; HUMANS; POLYETHYLENE GLYCOLS; POLYETHYLENEIMINE;

EID: 84931573842     PISSN: 19395116     EISSN: 19390041     Source Type: Journal    
DOI: 10.1002/wnan.1328     Document Type: Article

References (92)

1. Charman WN, Chan HK, Finnin BC, Charman SA. Drug delivery: a key factor in realizing the full therapeutic potential of drugs. Drug Dev Res 1999, 46:316-327.
2. Torchilin VP. Structure and design of polymeric surfactant-based drug delivery systems. J Control Release 2001, 73:137-172.
3. Muller-Goymann CC. Physicochemical characterization of colloidal drug delivery systems such as reverse micelles, vesicles, liquid crystals and nanoparticles for topical administration. Eur J Pharm Biopharm 2004, 58:343-356.
4. Soppimath KS, Aminabhavi TM, Kulkarni AR, Rudzinski WE. Biodegradable polymeric nanoparticles as drug delivery devices. J Control Release 2001, 70:1-20.
5. Gupta P, Vermani K, Garg S. Hydrogels: from controlled release to pH-responsive drug delivery. Drug Discov Today 2002, 7:569-579.
6. Archana D, Dutta J, Dutta PK. Evaluation of chitosan nano dressing for wound healing: characterization, in vitro and in vivo studies. Int J Biol Macromol 2013, 57:193-203.
7. Archana D, Singh BK, Dutta J, Dutta PK. In vivo evaluation of chitosan-PVP-titanium dioxide nanocomposite as wound dressing material. Carbohydr Polym 2013, 1:530-539.
8. Mehrdad H, Amir A, Pedram R. Hydrogel nanoparticles in drug delivery. Adv Drug Deliv Rev 2008, 60:1638-1649.
9. Klouda L, Mikos AG. Thermoresponsive hydrogels in biomedical applications. Eur J Pharm Biopharm 2008, 68:34-45.
10. Somali C, Keun K, Kinam P. Smart polymeric gels: redefining the limits of biomedical devices. Prog Polym Sci 2007, 32:1083-1122.
11. Alexander VK, Serguei VV. Nanogels as pharmaceutical carriers: finite networks of infinite capabilities. Angew Chem Int Ed 2009, 48:5418-5429.
12. Kwon J, Drumright R, Siegwart DJ, Matyjaszewski K. The development of microgels/nanogels for drug delivery applications. Prog Polym Sci 2008, 33:448-477.
13. Li YL, Zhu L, Liu Z, Cheng R, Meng F, Cui JH, Ji SJ, Zhong Z. Reversibly stabilized multifunctional dextran nanoparticles efficiently deliver doxorubicin into the nuclei of cancer cells. Angew Chem Int Ed 2009, 48:9914-9918.
14. Bae HH, Cho MY, Hong JH, Poo H, Sung MH, Lim YT. Bio-derived poly(gamma-glutamic acid) nanogels as controlled anticancer drug delivery carriers. J Microbiol Biotechnol 2012, 22:1782-1789.
15. Ichikawa H, Fukumori Y, Kamiya H. Functional stimuli responsive nanogels particle for oral peptide delivery: preparation, drug release behaviours and in vitro cellular interactions. NSTI: Nanotech 2006, 2:392-395.
16. Michael L, Eric S, Qin AW, Leah DD, Michael K, Joe C, Tarek MF. Nanogel-based delivery of mycophenolic acid ameliorates systemic lupus erythematosus in mice. J Clin Invest 2013, 123:1741-1749.
17. Schmitt F, Lagopoulos L, Kauper P, Rossi N, Busso N, Barge J, Wagnieres G, Carsten L, Christine W, Lucienne JJ. Chitosan-based nanogels for selective delivery of photosensitizers to macrophages and improved retention in and therapy of articular joints. J Control Release 2010, 144:242-250.
18. Singka GS, Samah NA, Zulfakar MH, Yurdasiper A, Heard CM. Enhanced topical delivery and anti-inflammatory activity of methotrexate from an activated nanogel. Eur J Pharm Biopharm 2010, 76:275-281.
19. Punit PS, Pinaki RD, Apurva RP, Mandip SS. Skin permeating nanogel for the cutaneous co-delivery of two anti-inflammatory drugs. Biomaterials 2012, 33:1607-1617.
20. Maki Y, Mikiro T, Kimiko N, Reiko K, Chisafujimoto SK. Epicutaneous application of toll like receptor 7 agonist leads to systemic autoimmunity in wild type mice, a new model of systemic lupus erythematosus. Arthritis Rheum 2014, 66:694-706.
21. Abu SNH, Heard CM. The effects of topically applied polyNIPAM-based nanogels and their monomers on skin cyclooxygenase expression ex vivo. Nanotoxicology 2014, 8:100-106.
22. Amit G, Ahmad FJ, Singh RM, Singh GN. Anti-inflammatory activity of nanogel formulation of 3-acetyl- 11-keto-β-boswellic acid. Pharmacologyonline 2009, 3:311-318.
23. Gopal K, Baby C, Mohammed A. Anti-inflammatory effect of amomum subula tumroxb fruits extract. Int J Pharm Sci Res 2012, 12:4722-4724.
24. Mudgil M, Gupta N, Nagpal M, Pawar P. Nanotechnology: a new approach for ocular drug delivery system. Int J Pharm Pharm Sci 2012, 2:105-112.
25. Moya-Ortega MD, Alvarez-Lorenzo C, Concheiro A, Loftsson T. Cyclodextrin-based nanogels for pharmaceutical and biomedical applications. Int J Pharm 2012, 428:152-163.
26. Kompella UB, Amrite AC, Pacha Ravi R, Durazo SA. Nanomedicines for back of the eye drug delivery, gene delivery, and imaging. Prog Retin Eye Res 2013, 36:172-198.
27. Kislay RJ, Kanwar R. Recent developments in ocular nanotherapy. Austin J Nanomed Nanotechnol 2014, 2:1-2.
28. Kim HJ, Zhang K, Moore L, Ho D. Diamond nanogel-embedded contact lenses mediate lysozyme-dependent therapeutic release. ACS Nano 2014, 8:2998-30052.
29. Chow EK, Zhang XQ, Chen M, Lam R, Robinson E, Huang H, Schaffer D, Osawa E, Goga A, Ho D. Nanodiamond therapeutic delivery agents mediate enhanced chemo resistant tumor treatment. Sci Transl Med 2011, 3:73.
30. Gupta H, Aqil M, Khar RK, Ali A, Bhatnagar A, Mittal G. Nanoparticles laden in situ gel of levofloxacin for enhanced ocular retention. Drug Deliv 2013, 20:306-309.
31. Zhang J, Misra GP, Lowe TL. Nanogels for ocular drug delivery to treat uveitis. In: Proceedings of the Annual Meeting Materials Engineering and Sciences Division. Thomas Jefferson University; 2010. ISBN: 978-0-8169-1064-9.
32. Mohammed N, Rejinold NS, Mangalathillam S, Biswas R, Nair SV, Jayakumar R. Fluconazole loaded chitin nanogels as a topical ocular drug delivery agent for corneal fungal infections. J Biomed Nanotechnol 2013, 9:1521-1531.
33. Sabitha M, Sanoj Rejinold N, Nair A, Lakshmanan VK, Nair SV, Jayakumar R. Development and evaluation of 5-fluorouracil loaded chitin nanogels for treatment of skin cancer. Carbohydr Polym 2013, 91:48-57.
34. Mangalathillam S, Rejinold NS, Nair A, Lakshmanan VK, Nair SV, Jayakumar R. Curcumin loaded chitin nanogels for skin cancer treatment via the transdermal Route. Nanoscale 2012, 7:239-250.
35. Shimoda A, Sawada S, Akiyoshi K. Cell specific peptide conjugated polysaccharide nanogels for protein delivery. Macromol Biosci 2011, 11:882-888.
36. Nochi T, Yuki Y, Takahashi H, Sawada S, Mejima M, Kohda T, Harada N, Kong IG, Sato A, Kataoka N, et al. Nanogel antigenic protein-delivery system for adjuvant-free intranasal vaccines. Nat Mater 2010, 9:572-578.
37. Alles N, Soysa NS, Hussain MD, Tomomatsu N, Saito H, Baron R, Morimoto N, Aoki K, Akiyoshi K, Ohya K. Polysaccharide nanogel delivery of a TNF-alpha and RANKL antagonist peptide allows systemic prevention of bone loss. Eur J Pharm Sci 2009, 37:83-88.
38. Sasaki Y, Iida D, Takahashi H, Sawada S, Akiyoshi K. Artificial chaperone polysaccharide nanogels for protein delivery: a thermodynamic study of protein-nanogel interactions using fluorescence correlation spectroscopy. Curr Drug Discov Technol 2011, 8:308-313.
39. Jin YJ, Ubonvan T, Kim DD. Hyaluronic acid in drug delivery systems. J Pharm Invest 2010, 40:33-43.
40. Akiyoshi K, Ayame H, Hasegawa U, Toita S, Asayama W, Morimoto N. Nanogel engineering for DDs: cationic polysaccharide nanogels for intracellular protein or quantum dot delivery. Polym Prepr 2006, 47:89-90.
41. Wang R, Zhang Y, Lu D, Ge J, Liu Z, Zare RN. Functional protein-organic/inorganic hybrid nanomaterials. WIREs Nanomed Nanobiotechnol 2013, 5:320-328.
42. Rejinold NS, Chennazhi KP, Tamura H, Nair SV, Rangasamy J. Multifunctional chitin nanogels for simultaneous drug delivery, bioimaging, and biosensing. ACS Appl Mater Interfaces 2011, 3:3654-3665.
43. Abu H, Abu Samah SH, Heard CM. Enhanced in vitro transdermal delivery of caffeine using a temperature and pH- sensitive nanogel, poly(NIPAM-co-AAc). Int J Pharm 2013, 453:630-640.
44. Shen JM, Xu L, Lu Y, Cao HM, Xu ZG, Chen T, Zhang HX. Chitosan-based luminescent/magnetic hybrid nanogels for insulin delivery, cell imaging, and anti diabetic research of dietary supplements. Int J Pharm 2012, 427:400-409.
45. Yeh TH, Hsu LW, Tseng MT, Lee PL, Sonjae K, Ho YC, Sung HW. Mechanism and consequence of chitosan-mediated reversible epithelial tight junction opening. Biomaterials 2011, 32:6164-6173.
46. Pujana MA, Leyre PA, Iturbe LCC, Katime I. Biodegradable chitosan nanogels cross linked with genipin. Carbohydr Polym 2013, 94:836-842.
47. Zubareva A, Ily'ina A, Prokhorov A, Kurek D, Efremov M, Varlamov V, Senel S, Ignatyev P, Svirshchevskaya E. Characterization of protein and peptide binding to nanogels formed by differently charged chitosan derivatives. Molecules 2013, 18:7848-7864.
48. Lee J, Lee C, Kim TH, Lee ES, Shin BS, Chi SC, Park ES, Lee KC, Youn YS. Self-assembled glycol chitosan nanogels containing palmityl-acylated exendin-4 peptide as a long-acting anti-diabetic inhalation system. J Controlled Release 2012, 161:728-734.
49. Singh N, Nisha, Gill V, Gill P. Nanogel based artificial chaperone technology: an overview. Am J Adv Drug Deliv 2013, 13:271-276.
50. Xu DM, Yao SD, Liu YB, Sheng KL, Hong J, Gong PJ, Dong L. Size-dependent properties of M-PEIs nanogels for gene delivery in cancer cells. Int J Pharm 2007, 338:291-296.
51. Sunasee R, Wattanaarsakit P, Ahmed M, Lollmahomed FB, Narain R. Biodegradable and non-toxic nanogels as nonviral gene delivery systems. Bioconjugate Chem 2012, 9:1925-1933.
52. Shi B, Zhang H, Qiao SZ, Bi J, Dai S. Intracellular microenvironment-responsive label-free auto fluorescent nanogels for traceable gene delivery. Adv Healthc Mater 2014, 3:1839-1848. doi:10.1002/adhm.201400187.
53. Ferreira SA, Gama FM, Vilanova M. Polymeric nanogels as vaccine delivery systems. Nanomed Nanotechnol Biol Med 2013, 9:159-173.
54. Ferreira SA, Oslakovic C, Cukalevski R, Frohm B, Dahlbäck B, Linse S, Gama FM, Cedervall T. Biocompatibility of mannan nanogel-safe interaction with plasma proteins. Biochim Biophys Acta 2012, 1820:1043-1051.
55. Atul PA, Praveen CD. Development and evaluation of nanogel as a carrier for transdermal delivery of aceclofenac. Asian J Pharm Technol 2012, 2:125-132.
56. Sharma A, Saini S, Rana AC. Transdermal drug delivery system: a review. Int J Res Pharm Biomed Sci 2013, 4:286-292.
57. Saad ZH, Jahan R, Bagul U. Nanopharmaceuticals: a new perspective of drug delivery system. Asian J Biomed Pharm Sci 2012, 14:11-20.
58. Prakash RTU, Thiagarajan P. Transdermal drug delivery systems influencing factors, study methods and therapeutic applications. Int J Pharm 2012, 2:366-374.
59. Yang F, Kamiya N, Goto M. Transdermal delivery of the anti-rheumatic agent methotrexate using a solid-in-oil nanocarrier. Eur J Pharm Biopharm 2012, 82:158-163.
60. Prasad S, Mukhopadhyay A, Kubavat A, Kelkar A, Modi A, Swarnkar B, Bajaj B, Vedamurthy M, Sheikh S, Mittal R. Efficacy and safety of a nano-emulsion gel formulation of adapalene 0.1% and clindamycin 1% combination in acne vulgaris: a randomized, open label, active-controlled, multicentric, phase IV clinical trial. Indian J Dermatol Venereol Leprol 2012, 78:459-467.
61. Jithan AV, Swathi N. Development of topical diclofenac liposomal gel for better anti inflammatory activity. Int J Pharm Sci Nanotechnol 2010, 3:986-993.
62. Kumar S, Talegaonkar S, Negi LM, Khan ZI. Design and development of ciclopirox topical nanoemulsion gel for the treatment of subungual onchomycosis. Indian J Pharm Educ Res 2012, 46:303-311.
63. Sunitha S, Wankar J, Ajimera T. Design, development and evaluation of nanoemulsion and nanogel of itraconazole for transdermal delivery. J Sci Res Pharm 2014, 3:6-11.
64. Rejinold NS, Nair A, Sabitha M, Chennazhi KP, Tamura H, Nair SV, Jayakumar R. Synthesis, characterization and in vitro cytocompatibility studies of chitin nanogels for biomedical applications. Carbohydr Polym 2012, 87:943-949.
65. Darouti MEI, Hay RA. Psoriasis: highlights on pathogenesis, adjuvant therapy and treatment of resistant and problematic cases. J Egypt Women Dermatol Soc 2010, 7:64-70.
66. Traub MND, Marshall KMS. Psoriasis-pathophysiology, conventional, and alternative approaches to treatment. Altern Med Rev 2007, 12:319-330.
67. Jabur MS, Ghazal MRI, Al-Hamamy HR. Topical methotrexate for treatment of psoriasis: formulation and clinical implications. J Fac Med Baghdad 2010, 52:32-36.
68. Lakshmi PK, Gayathri SD, Shyamala B. Niosomal methotrexate gel in the treatment of psoriasis phase I and phase II studies. Indian J Dermatol Venereol Leprol 2007, 73:157-161.
69. Baklaushev VP, Nukolova NN, Khalansky AS, Gurina OI, Yusubalieva GM, Grinenko NP, Gubskiy IL, Melnikov PA, Kardashova KS, Kabanov AV, et al. Treatment of glioma by cisplatin-loaded nanogels conjugated with monoclonal antibodies against Cx43 and BSAT1. Drug Deliv 2014, 1-10. doi: 10.3109/10717544.2013.876460.
70. Liu L, Gou M, Yi T, Bai Y, Wei Y, Zhao X. Antitumor effects of heparin-polyethyleneimine nanogels delivering claudin-3-targeted short hairpin RNA combined with low-dose cisplatin on ovarian cancer. Oncol Rep 2014, 31:623-628.
71. Nukolova NV, Oberoi HS, Zhao Y, Chekhonin VP, Kabanov AV, Bronich TK. LHRH-targeted nanogels as a delivery system for cisplatin to ovarian cancer. Mol Pharm 2013, 10:3913-3921.
72. Peng J, Qi T, Liao J, Chu B, Yang Q, Li W, Qu Y, Luo F, Qian Z. Controlled release of cisplatin from pH-thermal dual responsive nanogels. Biomaterials 2013, 34:8726-8740.
73. Jin W, Xu P, Zhan Y, Shen Y, Van Kirk EA, Alexander B, Murdoch WJ, Liu L, Isaak DD. Degradable cisplatin-releasing core-shell nanogels from zwitterionic poly(beta-aminoester)-graft-PEG for cancer chemotherapy. Drug Deliv 2007, 14:279-286.
74. Maeda K, Mochizuki S, Sanada Y, Sakurai K. Naphthalene-hydrophobized β-1, 3-glucan nanogel for doxorubicin delivery to immunocytes. Bioorg Med Chem Lett 2014, 24:1880-1883.
75. Chiang WH, Huang WC, Shen MY, Wang CH, Huang YF, Lin SC, Chern CS, Chiu HC. Dual-layered nanogel-coated hollow lipid/polypeptide conjugate assemblies for potential pH-triggered intracellular drug release. PLoS One 2014, 9:e92268.
76. Xiong MH, Bao Y, Du XJ, Tan ZB, Jiang Q, Wang HX, Zhu YH, Wang J. Differential anticancer drug delivery with a nanogel sensitive to bacteria-accumulated tumor artificial environment. ACS Nano 2013, 7:10636-10645.
77. Arunraj TR, Rejinold NS, Kumar NA, Jayakumar R. Bio-responsive chitin-poly(L-lactic acid) composite nanogels for liver cancer. Colloids Surf B Biointerfaces 2014, 113:394-402.
78. Jayakumar R, Nair A, Sanoj Rejinold N, Maya S, Nair SV. Doxorubicin-loaded pH-responsive chitin nanogels for drug delivery to cancer cells. Carbohydr Polym 2012, 87:2352-2356.
79. Kim JO, Oberoi HS, Desale S, Kabanov AV, Bronich TK. Polypeptide nanogels with hydrophobic moieties in the cross-linked ionic cores: synthesis, characterization and implications for anticancer drug delivery. J Drug Target 2013, 21:981-993.
80. Chiang WH, Ho VT, Chen HH, Huang WC, Huang YF, Lin SC, Chern CS, Chiu HC. Superparamagnetic hollow hybrid nanogels as a potential guidable vehicle system of stimuli-mediated MR imaging and multiple cancer therapeutics. Langmuir 2013, 29:6434-6443.
81. Deshmukh M, Kutscher HL, Gao D, Sunil VR, Malaviya R, Vayas K, Stein S, Laskin JD, Laskin DL, Sinko PJ. Biodistribution and renal clearance of biocompatible lung targeted poly(ethylene glycol) (PEG) nanogel aggregates. J Control Release 2012, 164:65-73.
82. Xing T, Mao C, Lai B, Yan L. Synthesis of disulfide-cross-linked polypeptide nanogel conjugated with a near-infrared fluorescence probe for direct imaging of reduction-induced drug release. ACS Appl Mater Interfaces 2012, 4:5662-5672.
83. Ashwinkumar N, Maya S, Jayakumar R. Redox-responsive cystamine conjugated chitin-hyaluronic acid composite nanogels. RSC Adv 2014, 4:49547-49555.
84. Jang B, Park JY, Tung CH, Kim IH, Choi Y. Gold nanorod-photosensitizer complex for near-infrared fluorescence imaging and photodynamic/ photothermal therapy in vivo. ACS Nano 2011, 5:1086-1094.
85. Rejinold NS, Ranjusha R, Balakrishnan A, Mohammed N, Jayakumar R. Gold-chitin-manganese dioxide ternary composite nanogels for radio frequency assisted cancer therapy. RSC Adv 2014, 4:5819-5825.
86. Chiang WH, Huang WC, Chang CW, Shen MY, Shih ZF, Huang YF, Lin SC, Chiu HC. Functionalized polymersomes with outlayered polyelectrolyte gels for potential tumor-targeted delivery of multimodal therapies and MR imaging. J Control Release 2013, 168:280-288.
87. Zhang X, Achazi K, Steinhilber D, Kratz F, Dernedde J, Haag R. A facile approach for dual-responsive prodrug nanogels based on dendritic polyglycerols with minimal leaching. J Control Release 2014, 174:209-216.
88. Arunraj TR, Rejinold NS, Kumar NA, Jayakumar R. Doxorubicin-chitin-poly(caprolactone) composite nanogel for drug delivery. Int J Biol Macromol 2013, 62:35-43.
89. Ding J, Xu W, Zhang Y, Sun D, Xiao C, Liu D, Zhu X, Chen X. Self-reinforced endocytoses of smart polypeptide nanogels for "on-demand" drug delivery. J Control Release 2013, 172:444-455.
90. Cai H, Yao P. In situ preparation of gold nanoparticle-loaded lysozyme-dextran nanogels and applications for cell imaging and drug delivery. Nanoscale 2013, 5:2892-2900.
91. Su S, Wang H, Liu X, Wu Y, Nie G. iRGD-coupled responsive fluorescent nanogel for targeted drug delivery. Biomaterials 2013, 4:3523-3533.
92. Wang C, Mallela J, Garapati US, Ravi S, Chinnasamy V, Girard Y, Howell M, Mohapatra S. A chitosan-modified graphene nanogel for non-invasive controlled drug release. Nanomedicine 2013, 9:903-911.